MedTrace Logo

VelaShape and Contour I V3 for Abdominal Fat Reduction vs. Control

NCT02553278 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-04-10

No results posted yet for this study

Summary

Prospective, 2-arm, clinical study for the evaluation of the VelaShape device and Contour I V3 device for non-invasive fat reduction vs. control.

All study subjects, who are scheduled for abdominoplasty, will undergo one treatment with VelaShape or Contour I V3 device.

Each arm will be treated with a different device:

Arm 1: subject will treated with VelaShape device Arm 2: subject will treated with Contour I V3 device

Conditions

  • Unwanted Abdomen Fat

Interventions

DEVICE

VelaShape device

Modified VelaShape radiofrequency device for non invasive fat reduction treatment.

DEVICE

Contour I V3 device

Contour I V3 device are non invasive for fat reduction.

Sponsors & Collaborators

  • Syneron Medical

    lead INDUSTRY

Principal Investigators

  • Dr. Dean Ad-El, M.D · Plastic surgery department , Blinson - Rabin Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-10
Primary Completion
2017-10-31
Completion
2017-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02553278 on ClinicalTrials.gov